Clinical Trials Conditions Document Packaging 
Cannabis Law Report
OCTOBER 6, 2021
Flora Pharma’s objective is to create and leverage a proprietary drug development platform in collaboration with an artificial intelligence and machine learning group to identify new bioactive compounds within the cannabis plant that interact with certain gene targets responsible for specific disease states and conditions.
Cannabis Law Report
JUNE 19, 2022
For example, compounds such as psilocybin, mescaline, ibogaine, and LSD are being evaluated in clinical trials, but the compounds themselves are unpatentable because their existence is well documented in the prior art. However, that does not mean that the path to patents is closed off. Originally Published At Microdose.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
NOVEMBER 19, 2021
It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. Ensure high quality, timely, and consistent submission of regulatory documents. European Regulatory Lead Executive Summary.
Cannabis Law Report
NOVEMBER 19, 2021
It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. Competitive benefit package includes: Paid Time Off (PTO). Why work for MAPS Public Benefit Corporation (MAPS PBC)? Holiday Pay.
Cannabis Law Report
SEPTEMBER 8, 2021
The Company provides proprietary cannabis processing services, in addition to best-in-class product development, manufacturing, and commercialization of cannabis consumer packaged goods. The conditions precedent for the execution of the Definitive Agreements are: a. . The Epsilon-Valens Management/Operational Consultancy.
Cannabis Law Report
JUNE 9, 2022
The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin. “; 6) Article 15 shall be worded as follows: “Article 15.
Cannabis Law Report
MARCH 29, 2020
This “zero recall” standard, the team said, was attributed to the fact that their cannabis product standards with regard to food safety and health was high and involved documentation of over 100 pages. . o Respondent checks: Age gates are in place to ensure compliance, and if underaged, then medical licenses must be checked.
Expert insights. Personalized for you.
52 
Let's personalize your content